Deal Snapshot
HIG CAPITAL CLOSES ACQUISITION OF TACONIC BIOSCIENCES
Friday 08 February 2019

An affiliate of US-based private equity firm H.I.G. Capital has partnered with the management team of Taconic Biosciences, Inc., to support the company's growth as a global provider of research models and services to the pharmaceutical, biotechnology, CRO, and academic research industries, the firm said.
Headquartered in Rensselaer, New York, with operations in Germantown, NY, Indiana, Germany, and Denmark, Taconic is a leader in genetically engineered models and service solutions used in mission-critical life sciences research.


TKUqg0 http://www.FyLitCl7Pf7kjQdDUOLQOuaxTXbj5iNG.com
Details
Date Published: 08/02/2019
Target: Taconic Biosciences, Inc
Country: USA
Sector: Pharmaceuticals
Type: MBO
Financing:
Status: Closed
Vendor:
Buyer: H.I.G. Capital, company management
Comment:
Terms of the deal were not disclosed

Options